Blunt Business

Crushed by Red Tape and Illicit Rivals: California and New York’s Cannabis Reality Check

While the broader cannabis market grapples with steep price compression, state-level missteps in both California and New York have turned promise into an uphill battle fo

Cultivating Better Care: How Humboldt Health is Revolutionizing Benefits for the Cannabis Industry

Humboldt Health is breaking new ground with a specialized healthcare captive tailored specifically for cannabis businesses with 50 to 2,000 employees. Blackwell Captive S

Hemp’s 30-Day Countdown on Regulation and Risk

As the timer ticks down on an impending federal crackdown, the hemp industry faces an existential race against the clock. Mainstream retailers—led by convenience store as

Berner Bets on Himself: Bringing Splash City to the Big Screen

In this episode of Blunt Business, Berner opens up about putting his own money on the line to co-write, co-direct, and produce his gritty Bay Area crime thriller, Splash

Cannabis Clashes with Legal Storms and Operational Shifts

The federal government’s increasing acknowledgment of medical cannabis applications marks a pivotal turning point for the sector, granting long-sought validation to consu

Cannabis Reform Takes Center Stage in the 2026 Midterms

As the 2026 midterm elections approach, marijuana reform is proving to be a rare unifying force across the political spectrum. Driven by high-stakes federal reschedulin

Retail Innovations and Local Access Roll Out for New Cannabis Customers

As the legal cannabis sector eagerly awaits federal reclassification judgments, industry players are aggressively pivoting toward untapped markets and hesitant, first-tim

Beyond the Hearings: Navigating Cannabis's Legal Crossroads

Although the historic DEA rescheduling hearings have officially concluded, the administrative process has ended without an immediate, final ruling, leaving the federal st

Navigating the DEA’s Cannabis Rescheduling Shift

As the DEA moves toward rescheduling cannabis, the industry is bracing for a complex transformation defined by regulatory uncertainty and potential legal headwinds. While

Future of Cannabusiness: Brand Strategy and Industry Consolidation

Joe Bayern with MM Brands outlines a strategic roadmap for professionalizing the cannabis industry, emphasizing that sustainable growth requires moving beyond fragmented

The Ongoing Federal Rescheduling and Operational Hurdles in Cannabis

Blunt Business welcomes Joe Bayern, the CEO of MM Brands to discuss how the cannabis industry is approaching a potential turning point as DOJ and DEA hearings conclude th

Banking, Compliance, and the DOJ Hearing for Cannabis Rescheduling

Once again we welcome back Nick Richards, Partner and co-chair of the cannabis law practice group at Greenspoon Marder about how the cannabis and hemp industries currentl

Courts, Cannabis, and Compliance: WNBA Policy Shifts vs. Impending Hemp Regulations

The sports industry is witnessing a landmark normalization of cannabis, highlighted by the WNBA’s recent collective bargaining agreement which removed cannabis from its p

DOJ Rescheduling Preview | Virginia Amending Adult Use | Illinois Introduces Hemp Ban?

We report on a wave of highly targeted legislative, legal, and medical updates aimed at curbing market disorder and protecting public health. In the United States, Virgi

Clarifying Cannabis From THCA Loopholes to Schedule III Shifts

Dr. Priyanka Sharma, co-CEO of Kazmira Therapeutics and fellow co-CEO Pulak Sharma, cut through the confusion surrounding the rapidly evolving cannabis and hemp sectors.

Kazmira Therapeutics and the Future of CBD Medicine

Kazmira Therapeutics is revolutionizing the CBD landscape by transitioning cannabinoids from over-the-counter health supplements to precision, pharmacist-compounded "real

The Hemp Lifeline: States Open Cannabis Gateways as Federal Lawsuit Targets MSOs

As a massive federal hammer prepares to fall on the hemp industry, progressive states are throwing operators a regulatory lifeline—just as the legal cannabis market faces

Federal Rescheduling and the BUILD Act: Capitol Hill’s Shift on Cannabis Reform

Blunt Business zeroes in on major developments unfolding on the congressional front. It highlights how impending federal rescheduling could significantly alter medical ca

Georgia Expands Medical Access and D.C. Beats Cannabis Lawsuit

This week on Blunt Business, we’re diving into two massive legal shifts reshaping cannabis markets on opposite sides of the country. First, we break down Georgia’s major

$15 Billion Refund? Navigating Retroactive 280E Relief

As the federal government moves toward rescheduling marijuana, the cannabis industry is eyeing a massive financial shift: the potential for $15 billion in retroactive tax